Keywords: merck, alendronate, filing, usa, soon, co, bisphosphonate

Merck's Alendronate: Filing In USA Soon?

Article | 27 February 1995

Print This

Merck & Co's bisphosphonate compound alendronate has been shown to increase bone density in the spine by 6.8% over a three-year study, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in